BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22696123)

  • 1. Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.
    Vigeveno RM; Wiebenga OT; Wattjes MP; Geurts JJ; Barkhof F
    J Magn Reson Imaging; 2012 Jul; 36(1):1-19. PubMed ID: 22696123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI in multiple sclerosis.
    Simon JH
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in multiple sclerosis; how to define occurence of progression.
    Brinar VV; Barun B
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S30-4. PubMed ID: 24321151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H; Geurts JJ
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
    Stadelmann C
    Curr Opin Neurol; 2011 Jun; 24(3):224-9. PubMed ID: 21455066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology.
    Filippi M; Rocca MA
    Acta Neurol Belg; 2011 Jun; 111(2):89-98. PubMed ID: 21748926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
    Jacobsen CO; Farbu E
    Acta Neurol Scand Suppl; 2014; (198):32-6. PubMed ID: 24588504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
    Zivadinov R; Minagar A
    J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
    Mandolesi G; Gentile A; Musella A; Fresegna D; De Vito F; Bullitta S; Sepman H; Marfia GA; Centonze D
    Nat Rev Neurol; 2015 Dec; 11(12):711-24. PubMed ID: 26585978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
    Mathiesen HK; Langkilde AR; Larsson HB
    Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging.
    Sicotte NL
    Neurol Clin; 2011 May; 29(2):343-56. PubMed ID: 21439445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.